The average twelve-month price target for SCYNEXIS is $25.67 with a high price target of $35.00 and a low price target of $20.00. SCYNEXIS Reports Inducement Grants . Score: -0.113. Home. Meanwhile, note that the median SCYX forecast price target (median being the middle where half of analysts had a higher SCYX forecast and half had a lower SCYX forecast, which is a different metric than the average or mean) was $24.25 as of 2022-02-09, while the highest SCYX forecast in the analyst group was $35.0, and the lowest SCYX forecast . The Score for SCYX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal. Value stocks will finally have their moment. Get the latest Scynexis SCYX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. NasdaqGM:SCYX Earnings and Revenue Growth February 13th 2022 Of course, another way to look at these forecasts is to place them into context against the industry itself. BofA forecasts the "lackluster" S&P 500 Index will finish 2022 at 4,600 points. The highest, average, and lowest price . 50/200 Day Moving Average: $6.5 / $6.7 . NASDAQ Stock Exchange > Drug Manufacturers . Find real-time SCYX - SCYNEXIS Inc stock quotes, company profile, news and forecasts from CNN Business. Stronger Stock . 's earnings in 2022 is -$46,334,000.. On average, 5 Wall Street analysts forecast SCYX's earnings for 2022 to be -$55,085,278, with the lowest SCYX earnings forecast at -$74,963,879, and the highest SCYX earnings forecast at -$29,219,148. Closed: Jan 14, 2022. - free SCYX analysis to find out whether to buy or sell SCYX. Scynexis Stock price prediction 2022 - (NASDAQ:SCYX) Scynexis Stock Future Price Prediction USD 5.63 0.36 6.83% Scynexis stock price prediction is an act of determining the future value of Scynexis shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. Scynexis. See more updates. SCYNEXIS Stock Forecast NASDAQ:SCYX. The International Energy Agency's (IEA) forecast suggests that global EV stock (excluding two/three-wheeler) will reach 145 million units by 2030, accounting for 7% of the global vehicle fleet. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey. Down from US$27.25, the current price target is an average from 6 analysts. March 16, 2022: EPS forecast (this quarter)-$0.74: Annual revenue (last year) $0.00: On Invalid Date, Scynexis (NASDAQ: SCYX) reported Q3 2021 earnings per share (EPS) of -$0.02, up 122.22% year over year. The analyst consensus target price for shares in SCYNEXIS is $23.50 . Scynexis Inc. Stock Predictons by days: 2021. SCYX | Complete SCYNEXIS Inc. stock news by MarketWatch. The minimum target price for SCYNEXIS analysts is $ 23.5 . Market forces rained on the parade of SCYNEXIS, Inc. ( NASDAQ:SCYX) shareholders today, when the analysts downgraded their forecasts for next year. 11:59AM. 52wk Low 4.21. SCYX Stock Analysis Overview. Insiders have sold a total of 504,000 SCYNEXIS shares in the last 24 months for a total of $4,003,110.00 sold. Find out now with a free analysis on Scynexis. It can be used to make informed decisions about market timing , and when buying or selling Scynexis shares will generate the highest return on investment. Search Stock, FX pair, Crypto, or Commodity. In a . As of 2022 January 26, Wednesday current price of SCYX stock is 4.750$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Scynexis stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. EV demand forecasts widely anticipate rising sales and market share between 2022 to 2030. SCYX Buy or Sell?Find out if you should buy SCYX stock. SCYNEXIS Address 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, US Market Capitalization: 124 059 000 $ The average price target is $19.50 with a high forecast of $22.50 and a low forecast of $16.00. Symbol Chart Company Open High Low Close Volume Percent; VERU: Veru Inc: 4.77 . January 10, 2022 ETF Daily News Team. The SCYX stock forecast is provided by MarketClub with their Trade Triangle system.. SCYX Stock Predictions . Toggle menubar . SCYNEXIS Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SCYX. Wall Street liked what CyberArk said about its progress in this transition. 05:30 AM ET. With those in mind, here are some new predictions for 2022 that I think have a solid chance of happening. SCYX Stock Analysis - [Full Report] SCYX Chart by TradingView. SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. Scynexis Inc Stock Forecast, "SCYX" Stock Predictons by days: 2021. What is Scynexis's Market Cap? The current put volume is at 12, with calls trading at the volume . SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. The share price of SCYNEXIS, Inc. (SCYX) now. In the medium term (3months), SSNT's stock price should underperform the market by . Based on our forecasts, a long-term increase is expected, the "SCYX" stock price prognosis for 2027-02-05 is 19.006 USD. Over the past . . SCYX Chart by TradingView. Analyst Price Target on SCYX. Coronavirus Pandemic Delays Testing of New Drugs The Wall Street Journal Interactive Edition. sander7100 yo bro predicted that SCYX for 2020-09-11 is going $6.22 (20.54%) 1 year ago. 52-week high/low: $10.25 / $4.21 . On average, analysts forecast that F's EPS will be $2.03 for 2022, with the lowest EPS forecast at $1.75, and the highest EPS forecast at $2.24. We would highlight that SCYNEXIS' revenue growth is expected to slow, with the forecast 42% annualised growth rate until the end of 2022 being well below the historical 86% p.a. Search Stock, FX pair, Crypto, or Commodity. If you are looking for stocks with good return, Scynexis Inc can be a profitable investment option. SCYNEXIS stock forecasts are adjusted once a day based on the closing price of the previous trading day. SCYX Stock Summary. Scynexis Inc quote is equal to 4.810 USD at 2022-02-12. Get SCYNEXIS Inc (SCYX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. SCYX Stock Predictions - will SCYX go up or down? Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. View the latest SCYX stock quote and chart on MSN Money. That is 374.75% above the last closing price of $4.95. Abeona Therapeutics Stock Forecast, ABEO stock price prediction. View SCYNEXIS, Inc. SCYX investment & stock information. Stock gains accelerate into the close: S&P 500 adds 2.4% and posts weekly advance, ending three-week losing streak . The SCYNEXIS stock price gained 1.41% on the last trading day (Tuesday, 8th Feb 2022), rising from $4.95 to $5.02. Scynexis stock price target cut to $15 from $40 at Maxim Group MarketWatch. Shares of SCYX stock opened at $5.02 on Wednesday. See what signals are being triggered and find all the latest price data and stock quotes for the SCYX stock. SCYNEXIS (SCYX) stock Forecast for 2022 - 2026. The average price target represents a 293.94% change from the last price of $4.95. Scynexis Inc Stock Price Forecast, "SCYX" Predictons for2026 SCYX Stock Forecast. Options Trading Secret; Best Stocks For January 2022; Best Trading Software; Top Options List; Following is a list of stocks that are similar to the penny stock SCYX. Weaker Hold SCYX: #7126. SCYX Stock Predictions. Positive news sentiment. Learn more. The company has a current ratio of 7.86, a quick ratio of 7.81 and a debt-to-equity ratio of 1.05. NasdaqGM:SCYX Earnings and Revenue Growth February 13th 2022 Of course, another way to look at these forecasts is to place them into context against the industry itself. In the medium term (3months), SCYX's stock price should underperform the market by -6.97%. This is 5.87% less than the trading day before Thursday, 10th Feb 2022. Sector: Healthcare. Analysts forecast that SCYNEXIS, Inc. (NASDAQ:SCYX) will announce sales of $1.30 million for the current fiscal quarter, according to Zacks Investment . What analysts predict:: $23.5 . February 10 2022 - 08:21AM Dow Jones News By Chris Wack Scynexis Inc. reported positive results from its Phase 3 study investigating the safety and efficacy of oral ibrexafungerp for prevention of. growth over the . The current SCYNEXIS Inc [ SCYX] share price is $4.81. Yahoo Movies UK 1/20/2022. They are provided . The business had revenue of $0.52 million for the quarter, compared to analysts' expectations of $0.50 million. , and has now gained 4 days in a row. It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The CEO, President & Director of SCYNEXIS, Inc. (NASDAQ:SCYX), Marco Taglietti, Just Bought 32% More Shares. Advisors Llc Perceptive's Scynexis shares are currently valued at $10.80M. SCYNEXIS Stock . It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. Key Data. 52wk High 10.25. Should I buy or sell SCYX? SCYX Buy or Sell? Scynexis operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. SCYX stock forecast Our latest prediction for Scynexis Inc's stock price was made on the Dec. 21, 2020 when the stock price was at 6.20$.. ©2022 Stock Scanner . It's pretty clear that there is an expectation that SCYNEXIS' revenue growth will slow down substantially, with revenues to the end of 2022 expected to display 42% growth on an . The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . sander7100 yo bro predicted that SCYX for 2020-09-08 is going $4.86 (-2.99%) 09:25 AM ET. JERSEY CITY, N.J., Feb. 10, 2022 -- SCYNEXIS (SCYX), Inc., a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced positive results from its global Phase 3 CANDLE study investigating the safety and efficacy of oral ibrexafungerp for prevention of recurrent . SCYX Stock Forecast - Is SCYX a buy or sell? Disclaimer: Stocksunder1.org does not endorse or suggest any of the securities which are returned in any of the searches or filters. It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous . The stock has a 50-day moving average of $6.10 and a 200-day moving average of $6.09. The company is forecast to post a net loss per share of US$1.02 next year compared to a net loss per share of US$5.15 last year. SCYNEXIS Inc Stock Forecast. During the day the stock fluctuated 8.56% from a day low at $4.79 to a day high of $5.20 . Scynexis stock price target raised to $22 from $17 at Maxim Group MarketWatch. Get Our PREMIUM Forecast Now, from ONLY $8.49! Is there a SCYNEXIS share price forecast for 2022? SCYNEXIS INC stock forecast: up to 5.02 USD SCYX stock price prognosis STOCK. 5 bold predictions for 2022. Forecast for Tue 05 Apr 2022 price 5.00 SCYNEXIS INC stock price forecast for further price development up to 0.02% (time horizon: 1 day) and price target of 5.02 USD. Is SCYNEXIS Inc Stock Undervalued? The stock has a market cap of $120.23 million, a price-to-earnings ratio of -1.13 and a beta of 1.95. Friday, 11th Feb 2022 SCYX stock ended at $4.81. Based on analysts offering 12 month price targets for SCYX in the last 3 months. (% of float 01/15/22) 12.75. What this means: Scynexis Inc (SCYX) gets an Overall Rank of 60, which is an above average rank under InvestorsObserver's stock ranking system. JS predicted that SCYX for 2020-09-11 is going $5.33 (3.29%) 1 year ago. ( NASDAQ: SCYX) Scynexis 's market cap is $123.82M, as of Feb 10, 2022. US Stock Forecast. For 2022, the company expects 36% ARR growth — the midpoint of a range between $530 million and $536 million. About the SCYNEXIS, Inc. stock forecast. Jan 7, 2022 9:40AM EST. In the short term (2weeks), SSNT's stock price should outperform the market by 0.67%.During that period the price should oscillate between -8.00% and +13.75%.. Based on 3 Wall Street analysts offering 12 month price targets for SCYNEXIS in the last 3 months. Last update: 02-02-2022, 7:13. SCYX's price/sales ratio is 9.93; that's higher than the P/S ratio of 84.66% of US stocks. Today 200 Day Moving Average is the resistance level ( 6.63 $). SCYX updated stock price target summary. This report focused on revenue estimates . Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month . SCYNEXIS Stock Forecast, Price & News $4.81 -0.30 (-5.87%) (As of 02/11/2022 12:00 AM ET) Today's Range $4.79 $5.20 50-Day Range $4.50 $7.50 52-Week Range $4.21 $10.25 Volume 177,588 shs Average Volume 251,326 shs Market Capitalization $115.20 million P/E Ratio N/A Dividend Yield N/A Beta 1.95 Profile Analyst Ratings Chart Competitors SCYX 5.11 0.06 (1.16%) Post-Market 0.01 (0.20%) 10,404. The reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.79) by $0.73. The number of shares of a security that have been sold short by investors. SSNT stock forecast Our latest prediction for SilverSun Technologies Inc's stock price was made on the Aug. 17, 2021 when the stock price was at 6.65$.. View Scynexis SCYX investment & stock information. Free Signup: Advanced stock screener. Total Scynexis earnings for the quarter were -$605.00 thousand. Scynexis Naive Prediction Price Forecast For the 18th of January 2022 Given 90 days horizon, the Naive Prediction forecasted value of Scynexis on the next trading day is expected to be 5.72 with a mean absolute deviation of 0.25, mean absolute percentage error of 0.11, and the sum of the absolute errors of 15.37. Stock analysis is the technique used by a trader or investor to examine and evaluate how Scynexis stock is reacting to, or reflecting on a current stock market direction and economic conditions. New target price is 273% above last closing price of US$6.68. Stock analysis is the technique used by a trader or investor to examine and evaluate how Scynexis stock is reacting to, or reflecting on a current stock market direction and economic conditions. This is 1.41% more than the trading day before Monday, 7th Feb 2022. Scynexis (NASDAQ: SCYX) is owned by 42.55% institutional shareholders, 29.03% Scynexis insiders, and 28.42% retail investors. View real-time stock prices and stock quotes for a full financial overview. Analysts covering SCYNEXIS currently have a consensus Earnings Per Share (EPS) forecast of -$1.00 for the next financial year. This is even as the company has delivered positive news . . In the same quarter last year, Scynexis's earnings per share (EPS) was $0.09. SCYX stock chart & analysis. Toggle navigation. SCYX Earnings Information. Toggle Search. Friday, March 27, 2020. Get the latest SCYNEXIS, Inc. SCYX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. . Stock market forecasts for 2022 are all over the place—ranging from projecting another above average year to predicting we are on the heels of a small pullback. According to the issued ratings of 4 analysts in the last year, the consensus rating for SCYNEXIS stock is Buy based on the current 4 buy ratings for SCYX. Scynexis Inc Stock Price Forecast, "SCYX" Predictons for2025 Top 10 Penny Stocks +123.42%: Free Sigup: Penny Stocks: . Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Short-term (time horizon: 2 weeks) SCYNEXIS INC share price prediction for . Analysts Estimate Scynexis (SCYX) to Report a Decline in Earnings: What to Look Out for 11/05/19-9:32AM EST Zacks Implied Volatility Surging for SCYNEXIS (SCYX) Stock Options 08/21/19-9:40AM EST Zacks This figure corresponds to the average price over the previous 50/200 days. 1. Scynexis Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and . SCYNEXIS, Inc. (SCYX) stock forecast and . SCYNEXIS last released its earnings data on November 10th, 2021. Scynexis 's market cap is calculated by multiplying SCYX 's current stock price of $5.17 by SCYX 's total outstanding shares of . That would mark just a 0 . SCYNEXIS (SCYX) Forecast for 2022 SCYNEXIS information and performance SCYNEXIS Inc is a pharmaceutical company dedicated to the discovery, development and commercialization of new antibacterial agents to meet unmet therapeutic needs. 1d 2d 5d 1mo 3mo 6mo 1yr 3yr. Breaking News • Jan 28, 2022. SCYX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels. Find the latest SCYNEXIS, Inc. (SCYX) stock quote, history, news and other vital information to help you with your stock trading and investing. This page was last updated on 2/13/2022 by MarketBeat.com Staff. It's pretty clear that there is an expectation that SCYNEXIS' revenue growth will slow down substantially, with revenues to the end of 2022 expected to display 42% growth on an . SCYNEXIS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for SCYNEXIS, INC. Stock | SCYX | US8112922005 In the short term (2weeks), SCYX's stock price should underperform the market by -2.07%.During that period the price should oscillate between -11.03% and +12.32%.. During the day the stock fluctuated 5.86% from a day low at $4.78 to a day high of $5.06. January 27, 2022. © SCYNEXIS, Inc. (SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced grants of stock options to two new employees to purchase an aggregate of 5,200 shares of SCYNEXIS (SCYX) common stock at a per share exercise price of $7.38, the closing . on SCYX's analyst rating history. SCYX SCYNEXIS — Stock Price and Discussion | Stocktwits. Scynexis' latest option contracts expiring on 2022-02-18 are carrying combined implied volatility of 11.39 with a put-to-call open interest ratio of 0.07 over 10 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-02-18. Close price at the end of the last trading day (Tuesday, 8th Feb 2022) of the SCYX stock was $5.02. Tuesday, July 21, 2020. These returns cover a period from January 1, 1988 through January 3, 2022. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month . Stock is up 17% over the past year. iHustle84 predicted that SCYX for 2020-09-11 is going $5.89 (14.15%) 1 year ago. It is typically expressed as a percentage of the total number of shares outstanding and is reported on a monthly basis. On average, analysts forecast that F's EPS will be $2.31 for 2023, with the lowest EPS forecast at $2.00, and the highest EPS forecast at $2.50. S cynexis ( NASDAQ: SCYX) stock has been battered in the past year as the stock price has dropped by 22.5%. Monday, January 25, 2016. SCYNEXIS NASDAQ Updated Feb 11, 2022 12:07 AM. Advisors Llc Perceptive is the largest individual Scynexis shareholder, owning 2.40M shares representing 10.02% of the company. Get a free SCYX technical analysis report to make a better Scynexis stock predictions on how the stock will perform in the near future. SCYNEXIS Stock Price (Quote) NASDAQ: SCYX. Meanwhile, Bank of America thinks the stock market will essentially be flat next year. JERSEY CITY, N.J., Feb. 03, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced grants of stock options and Restricted Stock Units ("RSUs") to five new employees.The grants consisted of stock options to purchase an aggregate of 41,000 . ©2022 Stocks Under $1. The best long-term & short-term Abeona Therapeutics share price prognosis for 2022, 2023, 2024, 2025 . - Try Now Risk-Free - Money-back guarantee! It can be used to make informed decisions about market timing , and when buying or selling Scynexis shares will generate the highest return on investment. Dive deeper with interactive charts and top stories of SCYNEXIS, INC.. . Simply Wall St. SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. These returns cover a period from January 1, 1988 through January 3, 2022. With a year-over-year growth in debt of 156.49%, Scynexis Inc's debt growth rate surpasses 93.37% of about US stocks.

Trans Maldivian Airways Careers, Sotheby's Tauranga Listings, Maplewood Candle Company, Farm And Table Kennebunkport, Thomas Muller Wallpaper, Django Kubernetes Livenessprobe, Illinois College Of Optometry, Detroit Autorama 2019 Winners,